Showing results (151-160 of 317) with videos related to
Sort By:
Pageof 32
Leukemia|April 15, 2005
Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant eraT A Alonzo, R J Wells, W G Woods, et al.Cancer|October 10, 2013
Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology GroupJason Canner, Todd A Alonzo, Janet Franklin, et al.Blood|December 31, 2002
Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemiaEric L Sievers, Beverly J Lange, Todd A Alonzo, et al.BMC Medical Research Methodology|January 22, 2009
Bias in trials comparing paired continuous tests can cause researchers to choose the wrong screening modalityDeborah H Glueck, Molly M Lamb, Colin I O'Donnell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941Beverly J Lange, Patricia Dinndorf, Franklin O Smith, et al.Blood|March 16, 2006
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group, Richard Aplenc, Todd A Alonzo, et al.Leukemia|September 24, 2004
PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer GroupM L Loh, M G Reynolds, S Vattikuti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Michael Loken, Robert B Gerbing, et al.Pediatric Blood & Cancer|October 16, 2013
BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupAndrew S Moore, Todd A Alonzo, Robert B Gerbing, et al.Pediatric Blood & Cancer|March 24, 2022
Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance?Kathryn L Laurie, Paul Lee, Alfred Rademaker, et al.Pageof 32